These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10710123)

  • 1. The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets.
    Becker EM; Schmidt P; Schramm M; Schröder H; Walter U; Hoenicka M; Gerzer R; Stasch JP
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):390-7. PubMed ID: 10710123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
    Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
    Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
    Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
    Holt AW; Martin DN; Shaver PR; Adderley SP; Stone JD; Joshi CN; Francisco JT; Lust RM; Weidner DA; Shewchuk BM; Tulis DA
    Cell Signal; 2016 Sep; 28(9):1364-1379. PubMed ID: 27302407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
    Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
    Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxynitrite causes phosphorylation of vasodilator-stimulated phosphoprotein through a PKC dependent mechanism.
    Aburima A; Riba R; Naseem KM
    Platelets; 2010; 21(6):421-8. PubMed ID: 20624010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
    Sudo T; Ito H; Kimura Y
    Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
    Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
    Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
    Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
    Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does nitric oxide mediate the vasodilator activity of nitroglycerin?
    Kleschyov AL; Oelze M; Daiber A; Huang Y; Mollnau H; Schulz E; Sydow K; Fichtlscherer B; Mülsch A; Münzel T
    Circ Res; 2003 Oct; 93(9):e104-12. PubMed ID: 14551241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
    Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
    Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
    Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody.
    Smolenski A; Bachmann C; Reinhard K; Hönig-Liedl P; Jarchau T; Hoschuetzky H; Walter U
    J Biol Chem; 1998 Aug; 273(32):20029-35. PubMed ID: 9685341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z; Ajdic J; Eigenthaler M; Du X
    Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
    Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.